IP Library Granted Patent US 12,721,944
Granted Patent B2
US 12,721,944 · App. 18/489,887 · Granted Sep 1, 2026

Drug delivery device

Inventors: Fabian Bürli (Stüsslingen, CH); Pascal Lagorgette (Bienne, CH)
Assignee: SENSILE MEDICAL AG
A61M5/14248A61M5/158A61M2005/14256A61M2005/1585A61M2202/0007A61M2202/04A61M2205/0216A61M2205/12A61M2209/088A61M2210/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,721,944
App. No.
18/489,887
Granted
Sep 1, 2026
Kind
B2
Abstract

A drug delivery device ( 1 ), including a delivery unit ( 3 ) comprising a subcutaneous delivery system including a needle support ( 10 ), an injection needle ( 9 ) mounted on the needle support, and an injection needle actuation mechanism configured to engage and slidably move the needle support from a retracted position where the injection needle is within a housing ( 2 ) of the drug delivery device to an extended delivery position where the injection needle projects through a skin contact wall of the housing. The needle actuation mechanism comprises a slider-crank linkage mechanism ( 11 ) comprising a crank rod ( 13 ) pivotally connected to the housing, a connecting rod ( 14 ) pivotally connected to the crank rod and pivotally connected to the slidable needle support ( 10 ), and a spring ( 12 ) biasing the slider-crank linkage mechanism from a first retracted position prior to use where the needle is fully inserted within the housing towards an extended position for drug administration and further to a second retracted position after use.

Claims (19)

1 . A drug delivery device, including a delivery unit comprising a subcutaneous delivery system including a slidable needle support, an injection needle mounted on the slidable needle support, and an injection needle actuation mechanism configured to engage and slidably move the slidable needle support from a retracted position where the injection needle is within a housing of the drug delivery device to an extended delivery position where the injection needle projects through a skin contact wall of the housing, wherein the needle actuation mechanism comprises a slider-crank linkage mechanism comprising a crank rod pivotally connected to the housing, a connecting rod pivotally connected to the crank rod and pivotally connected to the slidable needle support, and a spring biasing the slider-crank linkage mechanism from a first retracted position prior to use where the needle is fully inserted within the housing towards an extended position for drug administration and further to a second retracted position after drug administration, wherein the needle actuation mechanism further comprises a rotatable actuation disc having a radial cam including a blocking portion configured to hold the slider-crank linkage mechanism in the first retracted position, and a release portion configured to allow the slider-crank linkage mechanism to move.

2 . The drug delivery device of claim 1 , wherein the spring is a torsion spring having a first arm engaging a support structure of the housing and a second arm engaging the slider-crank linkage mechanism, wherein the support structure is statically assembled to the housing or forms part of the housing.

3 . The drug delivery device of claim 1 , wherein the spring is a tension or compression spring having a first end engaging a support structure of the housing and a second end engaging the crank rod or connecting rod of the slider-crank linkage mechanism, wherein the support structure is statically assembled to the housing or forms part of the housing.

4 . The drug delivery device of claim 1 , wherein the actuation disc is coupled to a pumping system of the drug delivery device.

5 . The drug delivery device of claim 1 , wherein the actuation disc is coupled to a rotor of a pump engine of the pumping system.

6 . The drug delivery device of claim 1 , further comprising a stopper configured to stop the slideable needle support or slider-crank linkage mechanism in the extended position for drug administration, the stopper configured to be displaced to release the slider-crank linkage mechanism after use and removal of the drug delivery device.

7 . The drug delivery device of claim 6 , wherein the stopper is flexibly, elastically, slidably or pivotally coupled to the housing.

8 . The drug delivery device of claim 6 , wherein the stopper is pivotally coupled to the housing via a pivot coupling.

9 . The drug delivery device of claim 6 , wherein the stopper forms a skin contact wall portion configured to be in abutment against the skin of the patient during drug administration.

10 . A drug delivery device, including a delivery unit comprising a subcutaneous delivery system including a slidable needle support, an injection needle mounted on the slidable needle support, and an injection needle actuation mechanism configured to engage and slidably move the slidable needle support from a retracted position where the injection needle is within a housing of the drug delivery device to an extended delivery position where the injection needle projects through a skin contact wall of the housing, wherein the needle actuation mechanism comprises a slider-crank linkage mechanism comprising a crank rod pivotally connected to the housing, a connecting rod pivotally connected to the crank rod and pivotally connected to the slidable needle support, and a spring biasing the slider-crank linkage mechanism from a first retracted position prior to use where the needle is fully inserted within the housing towards an extended position for drug administration and further to a second retracted position after drug administration, further comprising an actuation lock comprising a blocking pad engaging a radial cam on one side of the blocking pad and the crank rod or connecting rod on the other side of the blocking pad.

11 . The drug delivery device of claim 10 , wherein the actuation lock is pivotally mounted to the support structure, the actuation lock comprising an arm extending from a pivot coupling to the blocking pad.

12 . The drug delivery device of claim 10 , wherein the actuation lock comprises a disengagement finger configured to be engaged by the slidable needle support in the extended position such that the blocking pad is moved away from the radial cam.

13 . The drug delivery device of claim 10 , wherein the spring is a torsion spring having a first arm engaging a support structure of the housing and a second arm engaging the slider-crank linkage mechanism, wherein the support structure is statically assembled to the housing or forms part of the housing.

14 . The drug delivery device of claim 10 , wherein the spring is a tension or compression spring having a first end engaging a support structure of the housing and a second end engaging the crank rod or connecting rod of the slider-crank linkage mechanism, wherein the support structure is statically assembled to the housing or forms part of the housing.

15 . The drug delivery device of claim 10 , wherein the needle actuation mechanism further comprises a rotatable actuation disc having a radial cam including a blocking portion configured to hold the slider-crank linkage mechanism in the first retracted position, and a release portion configured to allow the slider-crank linkage mechanism to move.

16 . The drug delivery device of claim 15 , wherein the actuation disc is coupled to a pumping system of the drug delivery device.

17 . The drug delivery device of claim 15 , wherein the actuation disc is coupled to a rotor of a pump engine of the pumping system.

18 . The drug delivery device of claim 10 , further comprising a stopper configured to stop the slideable needle support or slider-crank linkage mechanism in the extended position for drug administration, the stopper configured to be displaced to release the slider-crank linkage mechanism after use and removal of the drug delivery device.

19 . A drug delivery device, including a delivery unit comprising a subcutaneous delivery system including a slidable needle support, an injection needle mounted on the slidable needle support, and an injection needle actuation mechanism configured to engage and slidably move the slidable needle support from a retracted position where the injection needle is within a housing of the drug delivery device to an extended delivery position where the injection needle projects through a skin contact wall of the housing, wherein the needle actuation mechanism comprises a slider-crank linkage mechanism comprising a crank rod pivotally connected to the housing, a connecting rod pivotally connected to the crank rod and pivotally connected to the slidable needle support, and a spring biasing the slider-crank linkage mechanism from a first retracted position prior to use where the needle is fully inserted within the housing towards an extended position for drug administration and further to a second retracted position after drug administration, further comprising a stopper configured to stop the slideable needle support or slider-crank linkage mechanism in the extended position for drug administration, the stopper configured to be displaced to release the slider-crank linkage mechanism after use and removal of the drug delivery device, wherein the stopper forms a skin contact wall portion configured to be in abutment against the skin of the patient during drug administration, wherein the skin contact wall portion comprises a needle orifice formed therethrough configured to allow the injection needle to pass therethrough between the extended and retracted positions.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2023
From: LAGORGETTE, PASCAL; BÜRLI, FABIAN
To: SENSILE MEDICAL AG
Reel/Frame 065285/0540 →
Priority Claims (1)
EP 22203156 · Oct 21, 2022 · regional
Continuity (2)
Related Publication 20240131254A1 · Apr 25, 2024
Related Publication 20240226425A9 · Jul 11, 2024
References Cited (59)
US 7726955B2 · Ryser et al. · 2010 [cited by applicant]
US 8282366B2 · Hilber et al. · 2012 [cited by applicant]
US 8382700B2 · Straessler et al. · 2013 [cited by applicant]
US 8957674B2 · Genoud et al. · 2015 [cited by applicant]
US 9222470B2 · Genoud et al. · 2015 [cited by applicant]
US 9302285B2 · Marbet et al. · 2016 [cited by applicant]
US 9610402B2 · Yavorsky · 2017 [cited by examiner]
US 9662621B2 · Beyer et al. · 2017 [cited by applicant]
US 10076605B2 · Marbet et al. · 2018 [cited by applicant]
US 10143798B2 · Marbet et al. · 2018 [cited by applicant]
US 10569011B2 · Dilanni · 2020 [cited by examiner]
US 10632249B2 · Marbet et al. · 2020 [cited by applicant]
US 10954928B2 · Burli et al. · 2021 [cited by applicant]
US 11009018B2 · Wyss et al. · 2021 [cited by applicant]
US 11009026B2 · Girschweiler et al. · 2021 [cited by applicant]
US 11022107B2 · Brandt et al. · 2021 [cited by applicant]
US 11160922B2 · Just · 2021 [cited by applicant]
US 11612687B2 · Marbet · 2023 [cited by applicant]
US 11744940B2 · Wieser et al. · 2023 [cited by applicant]
US 20020055711A1 · Lavi · 2002 [cited by examiner]
US 20080208139A1 · Scheurer · 2008 [cited by examiner]
US 20090030382A1 · Brandt et al. · 2009 [cited by applicant]
US 20100241063A1 · Straessler et al. · 2010 [cited by applicant]
US 20120046651A1 · Beyer et al. · 2012 [cited by applicant]
US 20140231549A1 · Thiemer et al. · 2014 [cited by applicant]
US 20160184512A1 · Marbet · 2016 [cited by examiner]
US 20160199590A1 · Schabbach · 2016 [cited by examiner]
US 20160213837A1 · Schabbach et al. · 2016 [cited by applicant]
US 20160213839A1 · Schabbach et al. · 2016 [cited by applicant]
US 20160339179A1 · Lemaire · 2016 [cited by examiner]
US 20190117880A1 · Hirschel · 2019 [cited by examiner]
US 20190160225A1 · Verlaak · 2019 [cited by examiner]
US 20200023122A1 · McCullough · 2020 [cited by examiner]
US 20210369957A1 · Wieser · 2021 [cited by examiner]
US 20220031940A1 · Hulliger et al. · 2022 [cited by applicant]
US 20220226567A1 · Pananen · 2022 [cited by examiner]
US 20230398289A1 · Wieser et al. · 2023 [cited by applicant]
US 20240033422A1 · Büchi et al. · 2024 [cited by applicant]
US 20240033423A1 · Muller et al. · 2024 [cited by applicant]
US 20240066541A1 · Perrier et al. · 2024 [cited by applicant]
US 20240082485A1 · Lagorgette et al. · 2024 [cited by applicant]
US 20240082486A1 · Lagorgette et al. · 2024 [cited by applicant]
US 20240091460A1 · Burli et al. · 2024 [cited by applicant]
US 20240157045A1 · Kostal et al. · 2024 [cited by applicant]
US 20240165325A1 · Burli · 2024 [cited by applicant]
US 20240173473A1 · Burli · 2024 [cited by applicant]
US 20240175431A1 · Mueller · 2024 [cited by applicant]
US 20240181153A1 · Kostal et al. · 2024 [cited by applicant]
EP 4035707 · 2022 [cited by applicant]
WO WO2007074363 · 2007 [cited by applicant]
WO WO2008065646 · 2008 [cited by applicant]
WO WO2008065646A1 · 2008 [cited by examiner]
WO WO2015015379 · 2015 [cited by applicant]
WO WO2018024625 · 2018 [cited by applicant]
WO WO2018060027 · 2018 [cited by applicant]
WO WO2019228895 · 2019 [cited by applicant]
WO WO2020069926 · 2020 [cited by applicant]
WO WO2022194611 · 2022 [cited by applicant]
Extended European Search Report for Application No. EP 22203156.9, Mar. 15, 2023, pp. 1-9. [cited by applicant]